National Institute for Allergy and Infectious Diseases, Cleveland, Ohio, United States, 24 July 1997: Tuberculosis vaccines: How close to human testing?

Tubercle and Lung Disease

Volumn 78, Issue 3-4, 1997, Pages 159-169

  Jacobs, G G ^a   Johnson, J L ^a   Boom, W H ^a   Wallis, R S ^a   Whalen, C C ^a   Ginsberg, A M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; DNA VACCINE;

CONFERENCE PAPER; MUTAGENESIS; PRIORITY JOURNAL; TRANSPOSON; TUBERCULOSIS; VACCINATION; BACTERIAL GENE; CLINICAL TRIAL; GENETICS; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RESEARCH; UNITED STATES;

BCG VACCINE; CLINICAL TRIALS; GENES, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; OHIO; RESEARCH; TUBERCULOSIS, PULMONARY; VACCINES, DNA;

EID: 0031300825     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(97)90022-8     Document Type: Conference Paper

References (0)